日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings

在日本真实世界临床环境中,甲氨蝶呤与戈利木单抗联合用于治疗类风湿性关节炎的剂量调整

Yamairi, Fumiko; Yano, Toshiro; Goto, Takashi; Iwasaki, Tomohisa

Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet's disease: a large-scale, long-term postmarketing surveillance in Japan

英夫利昔单抗治疗白塞氏病难治性葡萄膜视网膜炎的安全性和有效性:一项在日本开展的大规模、长期上市后监测研究

Ohno, Shigeaki; Umebayashi, Itsuro; Matsukawa, Miyuki; Goto, Takashi; Yano, Toshiro

High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.

类风湿关节炎患者基线时类风湿因子和抗 CCP 抗体滴度较高与循环基线 TNF 水平升高、药物水平降低和临床反应减少相关:RISING 研究的事后分析

Takeuchi Tsutomu, Miyasaka Nobuyuki, Inui Takashi, Yano Toshiro, Yoshinari Toru, Abe Tohru, Koike Takao

Efficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study

英夫利昔单抗剂量递增治疗日本银屑病患者的疗效和安全性:SPREAD 研究结果

Torii, Hideshi; Nakano, Masayuki; Yano, Toshiro; Kondo, Kazuoki; Nakagawa, Hidemi